SEARCH RESULTS for NOVARTIS AG

Recent Patent Assignments Patent Assignments - (Total found: 469)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
19-Apr-2018

(X0) 15294843: SCANNING OPTICAL PROBE WITH FLEXING MECHANISM

(A1) 20180103842: SCANNING OPTICAL PROBE WITH FLEXING MECHANISM

ALCON RESEARCH, LTD.

NOVARTIS AG

40099/66

19-Apr-2018

(X0) 15326291: METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST

(A1) 20170196809: METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

45577/48

19-Apr-2018

(X0) 15717171: OPTICAL COHERENCE TOMOGRAPHY CROSS VIEW IMAGING

(A1) 20180104100: OPTICAL COHERENCE TOMOGRAPHY CROSS VIEW IMAGING

ALCON RESEARCH, LTD.

NOVARTIS AG

44411/839

19-Apr-2018

(X0) 15784881: APPARATUS FOR CONTROLLING VACUUM DURING OCULAR SURGERY

(A1) 20180104388: APPARATUS FOR CONTROLLING VACUUM DURING OCULAR SURGERY

ALCON RESEARCH, LTD.

NOVARTIS AG

44083/562

19-Apr-2018

(X0) 15846464: MECHANICAL SUPPORT OF AN INDIRECT CONTACT LENS BY A SURGICAL MICROSCOPE DURING VITREORETINAL SURGERY

(A1) 20180103844: MECHANICAL SUPPORT OF AN INDIRECT CONTACT LENS BY A SURGICAL MICROSCOPE DURING VITREORETINAL SURGERY

ALCON RESEARCH, LTD.

NOVARTIS AG

44431/963

19-Apr-2018

(X0) 15784278: FORMED CUTTER FOR VITRECTOMY PROBE

(A1) 20180104101: FORMED CUTTER FOR VITRECTOMY PROBE

ALCON RESEARCH, LTD.

NOVARTIS AG

44735/325

18-Apr-2018

(X0) 15309283: PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE

(A1) 20170073716: PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE

NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.

NOVARTIS AG

45558/353

17-Apr-2018

(X0) 14925282: LENS HOLDER FOR CONTACT VITRECTOMY LENS

(A1) 20170119249: LENS HOLDER FOR CONTACT VITRECTOMY LENS

(B2) 9943226: LENS HOLDER FOR CONTACT VITRECTOMY LENS

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

36968/415

17-Apr-2018

(X0) 14769110: ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG

(A1) 20160008369: ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG

(B2) 9943520: ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

36387/763

13-Apr-2018

(X0) 15805453: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B

(A1) 20180094033: NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B

NOVARTIS PHARMA AG

NOVARTIS AG

45513/1

11-Apr-2018

(X0) 15693920: Ocular Implant With Stiffness Qualities, Methods Of Implantation And System

(A1) 20180071143: Ocular Implant With Stiffness Qualities, Methods Of Implantation And System

TRANSCEND MEDICAL, INC.

NOVARTIS AG

45496/925

10-Apr-2018

(X0) 15047127: BRAKE SYSTEM

(A1) 20170082819: BRAKE SYSTEM

(B2) 9939603: BRAKE SYSTEM

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

37768/854

10-Apr-2018

9936866: ADJUSTING LASER TREATMENT IN RESPONSE TO CHANGES IN THE EYE

9936866: ADJUSTING LASER TREATMENT IN RESPONSE TO CHANGES IN THE EYE

WAVELIGHT GMBH

N/A

N/A

NOVARTIS AG

34149/370

10-Apr-2018

(X0) 15024396: METHODS FOR TREATING HEMATOLOGIC CANCERS

(A1) 20160222121: METHODS FOR TREATING HEMATOLOGIC CANCERS

COSTIM PHARMACEUTICALS INC.

NOVARTIS AG

45479/750

10-Apr-2018

(X0) 15466128: NUCLEIC ACID ENCODING ANTI-IL-17A ANTIBODIES

(A1) 20170198035: NUCLEIC ACID ENCODING ANTI-IL-17A ANTIBODIES

(B2) 9938342: NUCLEIC ACID ENCODING ANTI-IL-17A ANTIBODIES

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

43305/321

10-Apr-2018

(X0) 15024396: METHODS FOR TREATING HEMATOLOGIC CANCERS

(A1) 20160222121: METHODS FOR TREATING HEMATOLOGIC CANCERS

COSTIM PHARMACEUTICALS INC.

NOVARTIS AG

45476/875

06-Apr-2018

(X0) 15272633: FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

(A1) 20170007606: FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

NOVARTIS PHARMA AG

NOVARTIS AG

45446/395

05-Apr-2018

(X0) 15710618: Glaucoma Treatment Device

(A1) 20180092775: Glaucoma Treatment Device

TRANSCEND MEDICAL, INC.

NOVARTIS AG

45389/955

05-Apr-2018

(X0) 15831775: OCULAR MODELING METHODS AND APPARATUS

(A1) 20180092524: OCULAR MODELING METHODS AND APPARATUS

ALCON PHARMACEUTICALS LTD.

NOVARTIS AG

45120/530

05-Apr-2018

(X0) 15831941: SYSTEMS AND METHODS FOR A SURGICAL TISSUE MANIPULATOR

(A1) 20180092702: SYSTEMS AND METHODS FOR A SURGICAL TISSUE MANIPULATOR

ALCON RESEARCH, LTD.

NOVARTIS AG

45386/835

04-Apr-2018

(X0) 15025852: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

(A1) 20160215288: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

NOVARTIS AG

45424/50

04-Apr-2018

(X0) 15025852: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

(A1) 20160215288: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

45423/849

04-Apr-2018

(X0) 15025852: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

(A1) 20160215288: ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS

NOVARTIS PHARMA AG

NOVARTIS AG

45424/150

03-Apr-2018

(X0) 14571374: QUICK-OPENING VENT VALVE FOR PHACO FLUIDICS ASPIRATION SYSTEM

(A1) 20160166742: QUICK-OPENING VENT VALVE FOR PHACO FLUIDICS ASPIRATION SYSTEM

(B2) 9931447: QUICK-OPENING VENT VALVE FOR PHACO FLUIDICS ASPIRATION SYSTEM

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

35034/414

03-Apr-2018

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(B2) 9932374: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

NOVARTIS AG

39498/827

03-Apr-2018

(X0) 14973214: POWERED CASE FOR ELECTRO-ACTIVE MEDICAL DEVICE BATTERY MANAGEMENT

(A1) 20170173344: POWERED CASE FOR ELECTRO-ACTIVE MEDICAL DEVICE BATTERY MANAGEMENT

(B2) 9931515: POWERED CASE FOR ELECTRO-ACTIVE MEDICAL DEVICE BATTERY MANAGEMENT

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

37463/114

03-Apr-2018

(X0) 14996418: SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE

(A1) 20160213743: SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE

(B2) 9931372: SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

N/A

NOVARTIS AG

38291/950

03-Apr-2018

(X0) 15163592: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(A1) 20160263216: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(B2) 9931399: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

NOVARTIS AG

39509/810

03-Apr-2018

(X0) 15064363: DUAL OPTIC, CURVATURE CHANGING ACCOMMODATIVE IOL HAVING A FIXED DISACCOMMODATED REFRACTIVE STATE

(A1) 20170258581: DUAL OPTIC, CURVATURE CHANGING ACCOMMODATIVE IOL HAVING A FIXED DISACCOMMODATED REFRACTIVE STATE

(B2) 9931202: DUAL OPTIC, CURVATURE CHANGING ACCOMMODATIVE IOL HAVING A FIXED DISACCOMMODATED REFRACTIVE STATE

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

37925/229

30-Mar-2018

(X0) 15328882: IL-15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS

(A1) 20170202924: IL-15 AND IL-15RALPHA HETERODIMER DOSE ESCALATION REGIMENS FOR TREATING CONDITIONS

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

45386/984

29-Mar-2018

(X0) 15275625: HEAT TUNABLE INTRAOCULAR LENS

(A1) 20180085213: HEAT TUNABLE INTRAOCULAR LENS

ALCON RESEARCH, LTD.

NOVARTIS AG

39854/1

29-Mar-2018

(X0) 15718571: BETA-LACTAMASE INHIBITORS

(A1) 20180086762: BETA-LACTAMASE INHIBITORS

NOVARTIS PHARMA AG

NOVARTIS AG

44236/771

29-Mar-2018

(X0) 15510414: COMBINATION THERAPIES OF EGFR INHIBITORS

(A1) 20170304443: COMBINATION THERAPIES OF EGFR INHIBITORS

NOVARTIS PHARMACEUTICALS CORPORATION

NOVARTIS AG

45373/339

29-Mar-2018

(X0) 15510414: COMBINATION THERAPIES OF EGFR INHIBITORS

(A1) 20170304443: COMBINATION THERAPIES OF EGFR INHIBITORS

NOVARTIS PHARMACEUTICALS CORPORATION

NOVARTIS AG

45373/910

29-Mar-2018

(X0) 15510414: COMBINATION THERAPIES OF EGFR INHIBITORS

(A1) 20170304443: COMBINATION THERAPIES OF EGFR INHIBITORS

NOVARTIS PHARMA AG

NOVARTIS AG

45374/803

29-Mar-2018

(X0) 15510414: COMBINATION THERAPIES OF EGFR INHIBITORS

(A1) 20170304443: COMBINATION THERAPIES OF EGFR INHIBITORS

NOVARTIS PHARMA AG

NOVARTIS AG

45377/426

29-Mar-2018

(X0) 15718571: BETA-LACTAMASE INHIBITORS

(A1) 20180086762: BETA-LACTAMASE INHIBITORS

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44235/971

29-Mar-2018

(X0) 15711984: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

(A1) 20180086716: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

45328/416

29-Mar-2018

(X0) 15711984: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

(A1) 20180086716: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

NOVARTIS PHARMA AG

NOVARTIS AG

45328/507

29-Mar-2018

(X0) 15711984: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

(A1) 20180086716: SUBSTITUTED INDAZOLES FOR TREATING TENDON AND/OR LIGAMENT INJURIES

NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION

NOVARTIS AG

45329/1

28-Mar-2018

(X0) 15587538: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

(A1) 20170298354: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

NOVARTIS PHARMA AG

NOVARTIS AG

45361/527

28-Mar-2018

(X0) 15587538: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

(A1) 20170298354: ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

45361/494

23-Mar-2018

(X0) 15705873: IMMUNOGENIC COMPOSITIONS

(A1) 20180036402: IMMUNOGENIC COMPOSITIONS

NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.

NOVARTIS AG

45315/595

22-Mar-2018

(X0) 15695608: SUBTRACTIVE EN FACE OPTICAL COHERENCE TOMOGRAPHY IMAGING

(A1) 20180078130: SUBTRACTIVE EN FACE OPTICAL COHERENCE TOMOGRAPHY IMAGING

ALCON RESEARCH, LTD.

NOVARTIS AG

43490/486

22-Mar-2018

(X0) 15704233: PROCESS FOR PRODUCING CONTACT LENSES WITH DURABLE LUBRICIOUS COATINGS THEREON

(A1) 20180081197: PROCESS FOR PRODUCING CONTACT LENSES WITH DURABLE LUBRICIOUS COATINGS THEREON

ALCON RESEARCH, LTD.

NOVARTIS AG

45129/379

22-Mar-2018

(X0) 15713021: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

(A1) 20180080046: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

43841/570

22-Mar-2018

(X0) 15272795: WIRELESS OPHTHALMIC SURGICAL FOOTSWITCH

(A1) 20180083621: WIRELESS OPHTHALMIC SURGICAL FOOTSWITCH

ALCON RESEARCH, LTD.

NOVARTIS AG

39833/520

22-Mar-2018

(X0) 15271833: SYSTEMS AND METHODS FOR TRACKING THE ORIENTATION OF SURGICAL TOOLS

(A1) 20180078315: SYSTEMS AND METHODS FOR TRACKING THE ORIENTATION OF SURGICAL TOOLS

ALCON RESEARCH, LTD.

NOVARTIS AG

39820/235

22-Mar-2018

(X0) 15565187: RNA-GUIDED GENE EDITING SYSTEM AND USES THEREOF

(A1) 20180080013: RNA-GUIDED GENE EDITING SYSTEM AND USES THEREOF

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

44009/74

22-Mar-2018

(X0) 15704205: HYDROGEL CONTACT LENSES WITH LUBRICIOUS COATING THEREON

(A1) 20180079158: HYDROGEL CONTACT LENSES WITH LUBRICIOUS COATING THEREON

ALCON RESEARCH, LTD.

NOVARTIS AG

45128/775